Inflammation and Increased Risk of Cardiovascular Disease

For years, experts have noted that up to 50% of men who have a heart attack do not have diabetes, high blood pressure, high cholesterol, do not smoke and are active. This has led to an exploration of other causes and risk factors of cardiac and cerebrovascular disease.

In recent years, studies have shown an increased risk of cardiovascular disease in patients with rheumatoid arthritis, in untreated psoriatic arthritis and in severe psoriasis. We can also add atopic eczema to the list of cardiovascular risk factors.

In a publication in the British Medical Journal, investigators noted that patients with severe atopic eczema had a 20% increase risk in stroke, 40 – 50% increase risk of a heart attack, unstable angina, atrial fibrillation and cardiovascular death. There was a 70% increased risk of heart failure. The longer the skin condition remained active the higher their risks.

The study looked at almost 380,000 patients over at least a 5 year period and their outcomes were compared to almost 1.5 million controls without the skin conditions. Data came from a review of medical records and insurance information in the United Kingdom.

It’s clear that severe inflammatory conditions including skin conditions put patients at increased risk. It remains to be seen whether aggressive treatment of the skin conditions with immune modulators and medications to reduce inflammation will reduce the risks?

It will be additionally interesting to see what modalities cardiologists on each side of the Atlantic suggest we should employ for detection and with what frequency? Will it be exercise stress testing or checking coronary artery calcification or even CT coronary artery angiograms? Statins have been used to reduce inflammation by some cardiologists even in patients with reasonable lipid levels? Should we be prescribing statins in men and women with these inflammatory skin and joint conditions but normal lipid patterns?

The correlation of inflammatory situations with increased risk of vascular disease currently raises more questions with few answers at the present time.

Advertisements

Concierge Medicine – My 15th Anniversary

I practiced general internal medicine from June 1979 until November 2003. Immediately after training I became an employed physician of an older internist covering my employer’s patients and building my practice for two years before embarking on my own.

I saw 20 or more patients per day in addition to providing hospital care and visiting patients as they recovered in nursing homes. As managed care made its clout felt by kidnapping our patient’s and trying to sell them back to us at 50 cents on the dollar, I helped form a 44 doctor multi-specialty group with its own lab, imaging center and after hours walk-in center. The hope was that a large group might have some negotiating leverage with insurers allowing us to take more time with our patients for more reasonable fees. They laughed at us.

Three years later, my associate and I went to the bank, took out a big personal loan and started our concierge practice. We did this primarily to be comfortable providing excellent care to patients. The system was broken and no medical leader, insurer, employer or politician was going to fix the broken system.

Year after year as our patient’s survived and grew older and more complicated, private insurers including CMS (Medicare) asked us to see them quicker, in shorter visits, but be more comprehensive. The insurers essentially wanted us to place a square peg in a round hole. Switching to a Concierge practice meant I would be caring for a small group of patient’s well at the cost of finding a new medical home for 2,200 existing patients. Switching to Concierge Medicine was our response to a broken system being pushed in a direction of more money and profits for administrators and insurers at the expense of patients and doctors.

In retrospect, I should have made this change five years sooner. The financial rewards are not very different – caring for a small patient panel that pay a membership fee as compared to an enormous panel of patients. The rewards to the patients’ and the doctor for doing a job well done are priceless.

We increased our visit time to 45 minutes from 10 minutes. We set aside 90 minutes for new patient visits. We made a point of continuing to care for our hospitalized patients while all our colleagues were turning that over to hospital employed physicians with no office practices. We provided same day visits and access to the doctor 24 hours a day, seven day a week with accessibility by phone or email. We had the time to advocate for our patient’s as they weaved their way through a bureaucratic mind numbing health care system that made filling a prescription as difficult as the science of launching a rocket into space.

The results of the change are striking. There are very few emergency admissions to the hospital. Falls and trauma, which are mostly not preventable, replaced heart attacks, strokes and abdominal catastrophes as reasons for hospitalizations. There are many fewer hospitalizations. There are fewer crises because we learn about the problems immediately and see the patient’s quickly. If necessary, we help them get access to specialty services.

We have the time and staff now to battle with insurers and third party administrators to get our patient’s what they need to regain their health and independence. When they need specialty care we get them the best; the people we go to ourselves both locally and nationally. We send them equipped with all the information and questions they need to ask about their health problem.

Concierge Medicine has additionally given us the time to teach future doctors. While this stewardship of the profession and launching of future physicians is immensely satisfying, it also makes us stay current and on top of the latest literature and advances.

I look forward to this coming celebration of my 15th year in concierge medicine. I see Direct Pay Practices developing which deliver concierge services to the masses for lower fees. It is a spin-off of “boutique “medicine” or Concierge Lite” as my advisor calls it. It is an attempt by young physicians to reestablish the doctor patient relationship and deliver care in a broken health system.

I am thankful to my patients, who took a chance and came on this journey with me. I look forward to caring for them for years to come.

Tamsulosin and the Risk of Dementia

The journal Pharmacoepidemiology and Drug Safety published and reviewed in the online journal Primary Care which examines whether men with enlarged prostates and symptoms of prostatism develop dementia more frequently if they take the drug tamsulosin to relieve the symptoms. As men age, under the influence of male hormones, the three lobed prostate normally increases in size. As the prostate enlarges, it impedes the flow of urine as it attempts to leave the bladder. Patients feel urgency, hesitancy, dribbling, sometimes leaking and a diminished stream. Sleep-awakening night time urination becomes an issue as well as difficulty fully emptying the bladder.  Minimal night time urine production produces the urge to void.

There are many non-pharmacological surgical treatments for this normal, age related, condition. Medications have been used for years to try to prevent surgery or defer it to a later date. tamsulosin works by inhibiting certain receptors on the muscle in the prostate causing relaxation of smooth muscle and increased flow of urine. The study authors used Medicare data to look at men aged 66 and older taking tamsulosin to reduce symptoms of an enlarged prostate. They compared these men to others taking no medication for BPH and to those taking medications that work by a different mechanism of action including terazosin, doxazosin, alfuzosin, dutasteride and finesteride. The data was collected from years 2006 – 2012.

The results showed that men taking tamsulosin had a propensity for negative changes in cognitive function at a higher rate than men taking other products. This was clearly not a straight cause and effect study proving that tamsulosin causes cognitive dysfunction. The authors and reviewers in accompanying editorials point out the many variables and flaws which may have contributed to the conclusion but emphasize that further defining studies need to be started to clear up the doubt raised by this review.

A VA study done years ago comes to mind in which Veterans who ultimately switched from medications for an enlarged prostate underwent surgery and were interviewed one year later about their feelings about the results and function after surgery. Almost 100% of the study group felt better after surgery and relieved that the side effects of their medications for an enlarged prostate were a thing of the past. They wondered why they waited so long to have surgery and felt they would have asked for it sooner had they realized the many ill effects the medication was causing. It may be time for a more aggressive approach to prostate surgery as opposed to medical treatment?

Experimental Drug Stops Parkinson’s Disease Progression in Mice

Researchers at Johns Hopkins University School of Medicine published an article in Nature Medicine Journal outlining how administration of a drug called NLY01 stopped the progression of Parkinson’s disease in mice specially bred to develop this illness for research purposes. The medication is an alternative form of several diabetic drugs currently on the market including Byetta, Victoza and Trulicity. Those drugs penetrate the blood brain barrier poorly. NLY01 is designed to penetrate the blood brain barrier.

In one study, researchers injected the mice with a protein known to cause severe Parkinsonian motor symptoms. A second group received the protein plus NLY01. That group did not develop any motor symptoms of Parkinson’s disease. The other group developed profound motor impairment.

In a second experiment, they took genetically engineered mice who normally succumb to the disease in slightly more than a year of life. Those mice, when exposed to NLY01, lived an extra four months.

This is positive news in the battle to treat and prevent disabling symptoms in the disease that affects over 1 million Americans. Human trials will need to be established with questions involving whether the drug is even safe in humans? If safety is proven then finding the right dosage where the benefits outweigh the risks is another hurdle. The fact that similar products are currently being used safely to treat Type II Diabetes is noteworthy and hopefully allows the investigation to occur at a faster pace.

Parkinson’s disease is a progressive debilitating neurologic disorder which usually starts in patient’s 60 years of age or greater. Patients develop tremors, disorders sleeping, constipation and trouble moving and walking. Over time the symptoms exacerbate with loss of the ability to walk and speak and often is accompanied by dementia.

Prostate Cancer, Digital Rectal Exams, PSA and Screening

The PSA blood test, to detect prostate cancer, clearly has saved lives according to numerous studies. The United States Preventive Task Force (USPTF) recognizes this but has decided that screening for prostate cancer is not a great idea in men aged 55-69. They point out the PSA can be elevated from an enlarged prostate, an inflamed or infected prostate, a recent orgasm while having sex and other causes.

Elevated PSAs led to trans-rectal ultrasound views of the prostate and biopsies of the prostate. These biopsies were uncomfortable, even painful, and often followed by inflammation and infection of the prostate. Many times the prostate biopsy was benign with no cancer detected. The USPTF felt the cost, worry, and potential side effects were a risk far outweighing the benefits of screening. They consequently came out against screening men in this age group.  Naturally this position produced a tidal wave of criticism from urologists and other.

So, the USPTF has produced new recommendations calling for patient education and making a shared decision whether or not to obtain a PSA measurement before you send it out. This is a bit confusing because we always discuss the pros and cons of a PSA before we draw it. Adult men are entitled to hear the pros and cons so they can make their own informed decision.

To complicate matters, a study out of McMaster University in Canada reveals physicians are poorly trained in performing a digital rectal exam. They cite the lack of experience coming out of school and going into training and cite numerous research studies showing a rectal exam is a low yield way to detect prostate cancer. They do not recommend performing digital rectal exams for prostate cancer screening.

This received much media hype and the blur between the efficiency of detecting prostate cancer via a rectal exam and the use of the rectal exam to detect rectal and colon disease has been lost. We perform digital rectal exams to detect prostate cancer and look at the perirectal area for disease. We test the strength and performance of the anal sphincter muscle. We feel for rectal polyps and growths and, in certain situations, test the stool for the presence of blood.

During my internal medicine training my teachers always required a digital rectal exam, stool blood test and slide of the stool as part of the exam. As trainees, we realized the invasiveness of the exam and did our best to be polite, gentle and caring. I always asked for permission first, and still do. How can you tell if something is abnormal if you haven’t performed normal exams?

Last but not least, Finesteride, a medicine used to shrink an enlarged prostate by inhibiting male hormones, has finally been shown to be protective against developing prostate cancer. A study published in the journal of the National Cancer Institute found that men taking it for 16 years had a 21 % lower incidence of prostate cancer.

Does Curcumin Use Help with Cognitive Dysfunction?

Recently, more and more patients have been adding curcumin or turmeric to their cooking to help with their memory. Curcumin is a metabolite of Turmeric and has been available in health food stores for years.

A study a few years back on Alzheimer’s patients published by J. Ringman and Associates showed no benefit in slowing the development of symptoms and no improvement in symptoms when supplied with curcumin. When they looked closely at their study, and analyzed the participant’s blood, they found that curcumin was not absorbed and never really entered the bloodstream.

Last month a study was published in the American Journal of Geriatric Psychiatry by Dr. Gary Small and colleagues. They looked at 40 patients with mild memory complaints aged 50 – 90.  Some were administered a placebo and others were administered nanoparticles of curcumin in a product called “Theracumin”. The participants were randomized and blinded to the product they were testing. The study designers felt the nanoparticles would be absorbed better than other products and would actually test whether this substance was helpful or not. At 18 months, memory improved in patients taking the nanoparticles of curcumin and they had less amyloid deposition in areas it usually found relating to Alzheimers Disease.

Robert Isaacson MD, the director of the Alzheimer’s Prevention Clinic at Weil Cornell Medicine and New York- Presbyterian, has been suggesting his patients cook with curcumin for years. Until the development of the Theracumin nanoparticles, cooking with curcumin was the best way to have it absorbed after ingestion. There is now some evidence to suggest that curcumin, in this specific nanoparticle form, may play a role in both the risk reduction and potential therapeutic management of Alzheimers Disease.

Fitness Lowers Your Risk of Dementia

Over the years I have read and passed on to my patients the benefits of exercise on quality of life and healthy aging. This hypothesis was supported by a recent publication in the journal “Primary Care” by Peter Lin, MD, CCFP. Dr Lin and colleagues followed a group of woman aged 38 to 60 years for 44 years to determine the relationship between fitness and development of dementia. They chose to follow 191 women from a group of 1462 patients and selected a balanced number of patients in each age group up to age 60. They performed a physical fitness test on the women in 1968 and then grouped them into high fitness category, intermediate fitness category and low fitness category based on their performance in the physical fitness test. The women then received neuropsychiatric evaluations in 1974, 1980, 1992, 2000, 2005 and 2009.

The patients within the high fitness group showed an 88% reduction in dementia rate compared to those with medium fitness. Those in the lowest fitness group had a 41% increase d risk of dementia compared to the medium fitness group. Those patients in the high fitness group who developed dementia showed symptoms 9.5 years later on average than the patients in the medium fitness group.

The message for young adults is simple. Stay fit at a high level doing something you enjoy and you may reduce your risk of developing dementia by up to 90%.